Kimal plc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Kimal plc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6645
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kimal plc (Kimal) is a medical equipment company that develops, manufactures and markets customised procedure packs and vascular access devices. The company’s products include soft tissue biopsy needles, bone marrow biopsy needles, catheter accessories, catheter lock solution, closure device, drainage products, fluid management, drapes, gowns and equipment covers. It provides infusion systems, haemodialysis monitor and guidewires, among others. Kimal offers services such as product training, contract manufacturing services, customer care and ordering information, patient scheduled management services and business to business services, among others. The company’s products are used in the therapeutic areas of cardiology, critical care, radiology, renal, oncology, hematology, nutrition and others. It supplies products through its distributor partners worldwide. Kimal is headquartered in Bromsgrove, the UK.

Kimal plc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kimal plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kimal plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kimal plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kimal plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Kimal plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kimal plc, Medical Equipment, Deal Details 10
Partnerships 10
Kimal Extends Distribution Agreement With AngioDynamics For Vascular Access Products 10
Kimal Extends Distribution Agreement With Tauropharm For Taurolock 11
Kimal Enters Into Distribution Agreement With AngioDynamics For Fluid Management And Vascular Products 12
Actuated Medical Enters Into Co-Marketing Agreement With Kimal For TubeClear System 13
Kimal plc – Key Competitors 14
Kimal plc – Key Employees 15
Kimal plc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Jul 13, 2017: Kimal prepares for further expansion 17
Corporate Communications 18
Jan 05, 2017: Kimal announce the appointment of Geoff Morris OBE 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Kimal plc, Medical Equipment, Key Facts, 2017 2
Kimal plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Kimal plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kimal plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kimal plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kimal plc, Deals By Market, 2012 to YTD 2018 8
Kimal plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kimal Extends Distribution Agreement With AngioDynamics For Vascular Access Products 10
Kimal Extends Distribution Agreement With Tauropharm For Taurolock 11
Kimal Enters Into Distribution Agreement With AngioDynamics For Fluid Management And Vascular Products 12
Actuated Medical Enters Into Co-Marketing Agreement With Kimal For TubeClear System 13
Kimal plc, Key Competitors 14
Kimal plc, Key Employees 15
Kimal plc, Subsidiaries 16

List of Figures
Kimal plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Kimal plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Kimal plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Kimal plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Kimal plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kimal plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Kimal plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kimal plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Kimal plc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Herbalife Nutrition Ltd (HLF):企業の財務・戦略的SWOT分析
    Herbalife Nutrition Ltd (HLF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • SQI Diagnostics Inc (SQD):企業の財務・戦略的SWOT分析
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. The company provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop …
  • Avanti Energy Inc (AVN):石油・ガス:M&Aディール及び事業提携情報
    Summary Avanti Energy Inc (Avanti Energy), formerly Overlord Capital Ltd is an oil and gas exploration and production company. The company acquires, explores and develops gas reserves in Central Italy. It re-develops the existing oil and gas reserves. Avanti Energy re-enters and drills new wells in …
  • Brembo SpA:戦略・SWOT・企業財務分析
    Brembo SpA - Strategy, SWOT and Corporate Finance Report Summary Brembo SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Rizal Commercial Banking Corp (RCB):電力:M&Aディール及び事業提携情報
    Summary Rizal Commercial Banking Corp (RCBC) is a commercial and financial banking service provider that offers corporate, commercial, and consumer banking, cash management, treasury, and remittance products and services. The company’s electronic banking services include mobile banking, internet ban …
  • El Paso Electric Company:企業の発電所・SWOT分析2018
    El Paso Electric Company - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • UniFirst Corp (UNF):企業の財務・戦略的SWOT分析
    UniFirst Corp (UNF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Famy Care Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Famy Care Ltd (Famy Care) is a healthcare products provider that research, develops and manufactures female reproductive health care products. The company manufactures hormonal and reproductive health care products including famy care. Its hormonal formulation products include combined oral …
  • Strauss Group Ltd.:企業の戦略・SWOT・財務情報
    Strauss Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Strauss Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kolon Industries Inc (120110):企業の財務・戦略的SWOT分析
    Kolon Industries Inc (120110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • enGene Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary enGene Inc (enGene) is a biotechnology company that focuses on transforming medicine by administering gene therapy as an oral drug. The company develops a mucosal immunotherapy platform for treating inflammatory bowel disease and diabetes. It also developed a non-viral gene-therapy platform …
  • OFG Bancorp (OFG):企業の財務・戦略的SWOT分析
    Summary OFG Bancorp (OFG) operates as a financial service provider that offers banking, treasury, and financial products and services. The company’s consumer banking and lending products comprise residential mortgages, consumer finance, auto loans, and credit cards. Its commercial banking products a …
  • Rand Worldwide Inc (RWWI):企業の財務・戦略的SWOT分析
    Summary Rand Worldwide Inc (Rand Worldwide) is a technology company that offers engineering design and information technology solutions. The company operates through divisions such as IMAGINiT technologies, ASCENT-center for technical knowledge, and Rand 3D. It provides 3D design engineering softwar …
  • Hewlett Packard Enterprise Company (HPE):企業の財務・戦略的SWOT分析
    Hewlett Packard Enterprise Company (HPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Gentex Corporation:企業の戦略・SWOT・財務情報
    Gentex Corporation - Strategy, SWOT and Corporate Finance Report Summary Gentex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bio Blast Pharma Ltd (ORPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bio Blast Pharma Ltd (Bioblast Pharma) is a clinical stage biotechnology company that discovers, delivers, and develops clinical therapies for patients with rare and ultra-rare genetic diseases. The company discovers and develops pipeline products using platforms such as cabaletta, a mutant …
  • Collegium Pharmaceutical Inc (COLL)-医療機器分野:企業M&A・提携分析
    Summary Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-te …
  • Precision Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical stage biotechnology company. The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor specific antigens, companion diagnostic programs, and diagnostic …
  • Le Chateau Inc. (CTU):企業の財務・戦略的SWOT分析
    Le Chateau Inc. (CTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Denbury Resources Inc.:企業の戦略・SWOT・財務情報
    Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆